Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 211 clinical trials
Featured trial
Multiple Sclerosis

perception of spasticity frequency and severity, walking impairment, sleep quality, muscle tone, pain levels, and psychiatric (mental) assessments, as well as the safety and tolerability. Insurance is not

spasticity
  • 0 views
  • 28 Oct, 2021
  • 1 location
Featured trial
An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing Arbaclofen Placarbil Safety in Subjects With Spasticity Associated With Multiple Sclerosis

An Open Label, 26-Week Study Assessing Arbaclofen Placarbil Safety and Efficacy in Subjects With Spasticity Associated With Multiple Sclerosis With an Addendum Open-Label, 36-Week Study Assessing

  • 199 views
  • 08 Nov, 2020
  • 1 location
Featured trial
CHAMP Project (Child Hand Arm Movement Project)

CHAMP Project (Child Hand Arm Movement Project)

  • 694 views
  • 08 Nov, 2020
  • 1 location
A Study to Assess the Safety and Efficacy of IPN10200 of in Adult Participants With Upper Limb Spasticity. (LANTIMA)

IPN10200 doses(s) that offer the best efficacy/safety profile when used for the treatment of Adult upper limb (AUL) spasticity.

  • 2 views
  • 21 Apr, 2022
  • 29 locations
A Study to Compare the Safety and Efficacy of Dysport® and Botox® in Adults With Upper Limb Spasticity. (DIRECTION)

This study is aiming to demonstrate the non-inferiority of AbobotulinumtoxinA (aboBoNT-A) versus OnabotulinumtoxinA (onaBoNT-A) as the primary safety endpoint, and the superiority of aboBoNT-A over onaBoNT-A with respect to duration of response as the key secondary efficacy endpoint when used at optimal doses according to approved prescribing information of each …

  • 0 views
  • 10 May, 2022
  • 34 locations
Study to Compare the Efficacy and Safety of NT 201 (Botulinum Toxin) With Placebo for the Treatment of Lower Limb Spasticity Caused by Stroke or Traumatic Brain Injury (PATTERN)

limb spasticity caused by stroke or traumatic brain injury (Main Period). Participants will be assigned to the treatment groups by chance and neither the participants nor the research staff who

  • 144 views
  • 05 May, 2022
  • 46 locations
Peripheral Modulation of Muscle Stiffness and Spasticity

This is a single-center, double-blind, randomized, placebo-controlled, cross-over Phase II trial of human recombinant hyaluronidase injections in individuals with post-stroke upper limb muscle stiffness. The investigators will recruit 50 subjects, 25 males and 25 females, who will be randomized to receive either hyaluronidase plus saline (treatment arm, n=25) or normal …

  • 0 views
  • 24 Mar, 2022
  • 1 location
Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity

Phase 2/3, randomized, double-blind, placebo-controlled, single-treatment, multicenter trial assessing the efficacy and safety of MYOBLOC for the treatment of lower limb spasticity, in adults

myobloc
hemiplegia
traumatic brain injury
stroke
  • 60 views
  • 13 Apr, 2022
  • 8 locations
Proprioceptive Training,Balance,Motor Function,Spastic Cerebral Palsy Patient

Study Design: Randomized Controlled Trial Settings: Study will be conducted at Mobility quest clinic, Lahore Sample size:37 in each group Control group receive : Routine physical therapy Experimental group receive : Routine physical therapy+proprioceptive training

  • 0 views
  • 10 Mar, 2022
  • 1 location
Neurofeedback to Improve Spasticity After Incomplete Spinal Cord Injury

After incomplete spinal cord injury (iSCI), many people still have control over their upper and/or lower limbs, but secondary conditions such as spasticity impair the function they have left

  • 0 views
  • 05 May, 2022